Analytical Data
-
Gene name
pstP
- Application
-
Alternative Names
pstP；mstp；ppp；Serine/threonine Protein phosphatase PstP
-
Species
E.coli
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P9WHW4
-
Expression Region
1-237aa
-
AA Sequence
MARVTLVLRYAARSDRGLVRANNEDSVYAGARLLALADGMGGHAAGEVASQLVIAALAHLDDDEPGGDLLAKLDAAVRAGNSAIAAQVEMEPDLEGMGTTLTAILFAGNRLGLVHIGDSRGYLLRDGELTQITKDDTFVQTLVDEGRITPEEAHSHPQRSLIMRALTGHEVEPTLTMREARAGDRYLLCSDGLSDPVSDETILEALQIPEVAESAHRLIELALRGGGPDNVTVVVAD
-
Molecular Weight
29.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on pstP recombinant protein is rooted in the growing understanding of bacterial pathogenesis and the mechanisms of host-pathogen interactions. pstP, a gene found in various pathogenic strains, encodes a secreted protein that plays a crucial role in modulating the immune response of the host. Studies have indicated that pstP is involved in bacterial survival within host cells and contributes to virulence by interfering with immune signaling pathways. As antibiotic resistance becomes a significant challenge in treating bacterial infections, understanding the function of such virulence factors is paramount for developing novel therapeutic strategies. Recombinant DNA technology allows for the production of pstP in vitro, enabling researchers to investigate its biochemical properties, immune evasion capabilities, and potential as a vaccine candidate. Additionally, the exploration of pstP's interaction with host cell receptors provides insights into the dynamic interplay between pathogens and the immune system, highlighting its potential role in vaccine development and immunotherapy. Overall, the study of pstP recombinant protein is essential for advancing our comprehension of bacterial infections and identifying innovative approaches to combat them.
